After This Answer From ActBlue's CEO, Republicans Should've Expected This Wouldn't Go Well
The AP Amazingly Declares in Court It Does Not Need to Follow Its...
Ignore All of the World Cup Meltdowns; This German Road Trip Account Marveling...
Spencer Pratt Isn’t Laughing at Jimmy Kimmel’s 'Jokes'
Here's What Victor Davis Hanson Has to Say About Graham Platner's Victory in...
Nine Convicted in Ohio Drug Ring That Mixed Fentanyl Trafficking With $4.5M COVID-19...
Democrat Calls Republicans Fascists, Wishes He Could 'Run Over' Trump at Congressional Bas...
8 Indicted for Allegedly Threatening University of Michigan Leaders, Jewish Federation
Massachusetts Doctor Sentenced to Nearly 5 Years for Healthcare Fraud, Tax Evasion, Money...
CENTCOM Confirms U.S. Resumes Strikes on Iran After Helicopter Shot Down
Democrat Rep. Summer Lee Says Equity Policies Are Only a Threat to White...
Romanian Man Sentenced to 5 Years, Ordered to Pay $11M for Walmart Card-Skimming...
Republicans Add to Narrow House Majority With New Member
Here's How Much Oil Went Through the Strait of Hormuz Under a 'Secret...
Philadelphia Teachers Just Admitted the Real Reason Behind the Failure of the Public...
OPINION

Stocks in the News: VF Corp, AbbVie, D.R. Horton

The opinions expressed by columnists are their own and do not necessarily represent the views of Townhall.com.
Stocks in the News: VF Corp, AbbVie, D.R. Horton

Welcome to John Ransom's Stocks In The News, where the headline meets the trendline.

Stocks in the News is produced by Ransom Notes Radio and Goodfellow, LLC. Crista Huff manages Goodfellow LLC, a website that recommends outperforming stocks using fundamental and technical analysis.            

Advertisement

Stock number one is:

V.F. Corp.(SYMBOL: VFC), and the headline says:

Strong First Quarter Beat  (Citi Research)

V.F. Corp., maker of Wrangler, Lee, The North Face and Timberland apparel, announced first quarter earnings per share of $2.43, handily beating the consensus estimate of $2.19.  Gross margins expanded 240 basis points year-over-year to a new high of 48.1%, reports Citi Research.

Wall Street projects V.F. Corp to grow earnings 12-13% per year for the next three years.  The dividend yield is 2%.

We recommended a “buy” on V.F. Corp. on February 15.  The stock is up $16 since then.  Growth stock investors and growth & income investors should jump in here.

Our Ransom Note trendline says:  BUY V.F. CORP.

VFC Chart

VFC data by YCharts

Stock number two is: 

Stock number two is AbbVie Inc. (SYMBOL: ABBV), and the headline says:

AbbVie Profit Beats Analysts’ Estimates in First Quarter  (Bloomberg)

“AbbVie Inc. reported earnings that beat analysts’ estimates on higher sales of the rheumatoid arthritis treatment Humira in the first quarter since the drugmaker was split from parent Abbott Laboratories,” reports Bloomberg.  Prospects for Humira sales continue to grow with potential treatments for Hepatitis C, psoriasis and ulcerative colitis.

Advertisement

Earnings are projected to grow 3% this year.  The dividend yield is 3.54%, and the long-term debt ratio is 81%.

The stock broke past $39 on March 25, and is still on an uptrend.  Growth & income investors should retain their shares, but be aware that eps growth is slow and debt is high.

Our Ransom Note trendline says:  HOLD ABBVIE SHARES.

ABBV Chart

ABBV data by YCharts

Stock number three is:

Stock number three is D.R. Horton (SYMBOL: DHI), and the headline says:

D.R. Horton Profit More Than Doubles on Rising Home Sales  (Bloomberg)

D.R. Horton Inc., the largest U.S. homebuilder by volume, reported a blowout second quarter on increased volume and gross margins.  Earnings per share came in at 32 cents vs. analysts’ expected 19 cents, and 13 cents a year ago.  New home closings rose to 5,643; 9% higher than the market expected; and SG&A expenses were 5% lower than expected.

Earnings are projected to grow between 44% and 51% per year for each of the next three years.

The stock appears to be breaking out today, after trading between $21 and $25 for three months.  There is additional price resistance at $30.  On February 26, we told investors to “buy now at $22”.  We reiterated our Buy recommendation on March 26.

Advertisement

Our Ransom Note trendline says:  BUY D.R. HORTON.

DHI Chart

DHI data by YCharts

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement